SEC Form 4 · accession 0001127602-19-008334
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 3:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | S | 200 | $144.605 | D | 313,167 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.61 | D | 312,967 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.615 | D | 312,767 | D | |
| Common Stock | Feb 25, 2019 | S | 603 | $144.62 | D | 312,164 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.625 | D | 311,964 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $144.63 | D | 311,664 | D | |
| Common Stock | Feb 25, 2019 | S | 323 | $144.65 | D | 311,341 | D | |
| Common Stock | Feb 25, 2019 | S | 208 | $144.655 | D | 311,133 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $144.66 | D | 310,733 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.67 | D | 310,633 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.675 | D | 310,533 | D | |
| Common Stock | Feb 25, 2019 | S | 158 | $144.68 | D | 310,375 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.69 | D | 310,175 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.70 | D | 310,075 | D | |
| Common Stock | Feb 25, 2019 | S | 996 | $144.705 | D | 309,079 | D | |
| Common Stock | Feb 25, 2019 | S | 600 | $144.71 | D | 308,479 | D | |
| Common Stock | Feb 25, 2019 | S | 142 | $144.715 | D | 308,337 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $144.73 | D | 308,037 | D | |
| Common Stock | Feb 25, 2019 | S | 377 | $144.735 | D | 307,660 | D | |
| Common Stock | Feb 25, 2019 | S | 700 | $144.74 | D | 306,960 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.75 | D | 306,760 | D | |
| Common Stock | Feb 25, 2019 | S | 36 | $144.765 | D | 306,724 | D | |
| Common Stock | Feb 25, 2019 | S | 1,000 | $144.77 | D | 305,724 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.